Govaert, Klaas M <br/><br/>
Hypoxia after liver surgery imposes an aggressive cancer stem cell phenotype on residual tumor cells.  [electronic resource] 

 -  Annals of surgery  Apr 2014 
 - 750-9 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-1140 
<br/><br/><label>Standard No.: </label>10.1097/SLA.0b013e318295c160  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Biomarkers, Tumor--metabolism<br/>Blotting, Western<br/>Catheter Ablation<br/>Cell Line, Tumor<br/>Colorectal Neoplasms--pathology<br/>Flow Cytometry<br/>Hematopoietic Stem Cells--pathology<br/>Hepatectomy--methods<br/>Humans<br/>Hypoxia--etiology<br/>Immunohistochemistry<br/>Liver Neoplasms, Experimental--metabolism<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Inbred NOD<br/>Mice, Nude<br/>Mice, SCID<br/>Neoplasm Invasiveness--pathology<br/>Neoplasm Micrometastasis--pathology<br/>Neoplasm Recurrence, Local--metabolism<br/>Neoplasm, Residual--metabolism<br/>Neoplastic Stem Cells--metabolism<br/>Phenotype<br/>Postoperative Complications--metabolism<br/>Real-Time Polymerase Chain Reaction<br/>Reperfusion Injury--etiology<br/>Tirapazamine<br/>Triazines--therapeutic use